Structural Formula Of Cabotegravir (Apretude Spl Graphic 01)
Apretude Kit
Product Images NDC 49702-264
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Apretude (NDC 49702-264). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Viiv Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1. Cumulative Incidence Of Hiv-1 Infections In Hptn 083 (Apretude Spl Graphic 02)
Figure 2. Cumulative Incidence Of Hiv-1 Infections In Hptn 084 (Apretude Spl Graphic 03)
Instructions For Use Header (Apretude Spl Graphic 04)
INSTRUCTIONS FOR USE: "Pretude" is an extended-release injectable suspension with 600 mg/3 mL dosage (200 mg/mL). It is intended for intramuscular use only in the gluteal region of the body.*
Storage Information (Apretude Spl Graphic 05)
Kit Contents (Apretude Spl Graphic 06)
The text describes a medical device called "APRETUDE vial Vial adapter" that includes a vial cap with a rubber stopper underneath. The device also involves a syringe with an injection needle, a plunger, a needle guard, and a needle cap.*
Figure A (Apretude Spl Graphic 07)
This text is a simple reminder to check the expiration date of medicine before use.*
Figure B (Apretude Spl Graphic 08)
Figure C (Apretude Spl Graphic 09)
Figure D (Apretude Spl Graphic 10)
Figure E (Apretude Spl Graphic 11)
Figure F (Apretude Spl Graphic 12)
Figure G (Apretude Spl Graphic 13)
Figure H (Apretude Spl Graphic 14)
Figure I (Apretude Spl Graphic 15)
Figure J (Apretude Spl Graphic 16)
Figure K (Apretude Spl Graphic 17)
Figure L (Apretude Spl Graphic 18)
Figure M (Apretude Spl Graphic 19)
Figure N (Apretude Spl Graphic 20)
Figure O (Apretude Spl Graphic 21)
Figure P (Apretude Spl Graphic 22)
Figure Q (Apretude Spl Graphic 23)
Figure R (Apretude Spl Graphic 24)
Figure S (Apretude Spl Graphic 25)
Not available.*
Apretude 3 mL Kit Carton (Apretude Spl Graphic 26)
Apretude is a prescription medication for healthcare professional administration only. It is an injectable suspension containing 600 mg/3 mL cabotegravir extended-release. It should only be administered into the gluteal muscle, using the vial adapter, syringe, and 23 gauge, 1% inch injection needle provided. Prescribing information, patient information, and instructions for use are also included. The National Drug Code for this medication is 49702-264-23.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
